Mouse Anti-GM2A Recombinant Antibody (CF186) (CBMAB-FT297LY)

Name: Mouse Anti-GM2A Recombinant Antibody (CF186)
SKU: CBMAB-FT297LY
Rating: 5 (1 reviews)

See all GM2A antibodies

Compare Online Inquiry

Datasheet

SDS

Request for COA

Datasheet Target References Q & As Review & reward Protocols Associated Products

Basic Information

Host Animal

Mouse

Clone

CF186

Application

ELISA, WB

Immunogen

GM2 ganglioside activator

Specificity

Human

Antibody Isotype

IgG2a

Clonality

Monoclonal

Application Notes

The COA includes recommended starting dilutions, optimal dilutions should be determined by the end user.

Formulations & Storage [For reference only, actual COA shall prevail!]

Format

Liquid

Buffer

50% glycerol

Preservative

0.02% sodium azide

Storage

Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freezethaw cycles.

More Infomation

Target

Full Name

GM2 Ganglioside Activator

Introduction

This gene encodes a small glycolipid transport protein which acts as a substrate specific co-factor for the lysosomal enzyme beta-hexosaminidase A. Beta-hexosaminidase A, together with GM2 ganglioside activator, catalyzes the degradation of the ganglioside GM2, and other molecules containing terminal N-acetyl hexosamines. Mutations in this gene result in GM2-gangliosidosis type AB or the AB variant of Tay-Sachs disease. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2009]

Entrez Gene ID

2760

UniProt ID

P17900

Alternative Names

Ganglioside GM2 activator, GM2 AP, GM2 ganglioside activator, GM2A, SAP 3

Function

The large binding pocket can accommodate several single chain phospholipids and fatty acids, GM2A also exhibits some calcium-independent phospholipase activity (By similarity).

Binds gangliosides and stimulates ganglioside GM2 degradation. It stimulates only the breakdown of ganglioside GM2 and glycolipid GA2 by beta-hexosaminidase A. It extracts single GM2 molecules from membranes and presents them in soluble form to beta-hexosaminidase A for cleavage of N-acetyl-D-galactosamine and conversion to GM3 (By similarity).

Has cholesterol transfer activity (PubMed:17552909).

Biological Process

Ganglioside catabolic process Source: GO_Central
Glycosphingolipid metabolic process Source: Reactome
Learning or memory Source: Ensembl
Lipid storage Source: Ensembl
Lipid transport Source: GO_Central
Neuromuscular process controlling balance Source: Ensembl
Oligosaccharide catabolic process Source: Ensembl
Positive regulation of hydrolase activity Source: Ensembl

Cellular Location

Lysosome

Involvement in disease

GM2-gangliosidosis AB (GM2GAB):
An autosomal recessive lysosomal storage disease marked by the accumulation of GM2 gangliosides in the neuronal cells. It is characterized by GM2 gangliosides accumulation in the presence of both normal hexosaminidase A and B.

PTM

The serines in positions 32 and 33 are absent in 80% of the sequenced protein.

Hsieh, Y. C., Negri, J., He, A., Pearse, R. V., Liu, L., Duong, D. M., ... & Young-Pearse, T. L. (2022). Elevated ganglioside GM2 activator (GM2A) in human brain tissue reduces neurite integrity and spontaneous neuronal activity. Molecular neurodegeneration, 17(1), 61.

Xiao, C., Toro, C., & Tifft, C. (2022). GM2 Activator Deficiency. GeneReviews®[Internet].

Kafaei Shahbaz, N. (2022). The Role of GM2 Activator Protein in Breast Cancer Metastasis and the EGFR Signaling Pathway (Doctoral dissertation).

Yuan, J., Li, Z., Lin, Z., Yao, S., Han, Y., Fu, Q., & Liu, J. (2022). Label-free quantitative proteomics reveals the Steap3-Gm2a axis inhibiting the phagosomal escape of Listeria monocytogenes. Microbes and Infection, 24(8), 104999.

Beeler, K., Vowinckel, J., Soste, M., Mallardo, D., Capone, M., Gabriele, M., ... & Ascierto, P. (2020). 229 Discovery of ganglioside GM2 activator as a novel proteomic biomarker associated with response to treatment in first-line melanoma subjects treated with PD-1 immunotherapy.

Holzer, K., Drucker, E., Waldburger, N., Eiteneuer, E., Breuhahn, K., Ori, A., ... & Singer, S. (2018). Ganglioside GM2 activator (GM2A) is as a novel pro-survival p53 target in hepatocellular carcinoma. Zeitschrift für Gastroenterologie, 56(01), A4-44.

Ask a question We look forward to hearing from you.

0 reviews or Q&As

Purchasing FAQs
Technical FAQs

Have you used Mouse Anti-GM2A Recombinant Antibody (CF186)?
Submit a review and get a Coupon or an Amazon gift card. 20% off Coupon

$30 eGift Card
Submit a review

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols

Related Products

Mouse Anti-GM2A Recombinant Antibody (CBLG1-3191) (CAT#: CBMAB-G3992-LY)

Mouse Anti-GM2A Recombinant Antibody (347) (CAT#: CBMAB-AP2567LY)

Mouse Anti-GM2A Recombinant Antibody (CBLG1-1351) (CAT#: CBMAB-G3993-LY)

Mouse Anti-GM2A Recombinant Antibody (2C8) (CAT#: CBMAB-G3991-LY)

Mouse Anti-GM2A Recombinant Antibody (CBLG1-1353) (CAT#: CBMAB-G3995-LY)

Isotype control

For research use only. Not intended for any clinical use.

Custom Antibody Labeling

We also offer labeled antibodies developed using our catalog antibody products and nonfluorescent conjugates (HRP, AP, Biotin, etc.) or fluorescent conjugates (Alexa Fluor, FITC, TRITC, Rhodamine, Texas Red, R-PE, APC, Qdot Probes, Pacific Dyes, etc.).

Online Inquiry

Request bulk or custom quote Second antibody and isotype control

Contact us

Tel: (USA)
(UK)
Fax:

Global Locations

Email:

Online Inquiry